AKL Therapeutics

AKL Therapeutics

Pharmaceutical Manufacturing

Stevenage, England 501 followers

Focused on inflammatory diseases, particularly those related to dysregulation of the innate immune system

About us

AKL Therapeutics is a pharmaceutical company changing the way drugs are developed by seeking inspiration from nature to combat some of the biggest challenges facing modern medicine today. We are committed to transforming patient’s lives through pioneering innovation. We begin by identifying secondary metabolites of plant origin, with proven efficacy and safety. These metabolites are then synthesized before undergoing standard pharmaceutical clinical development. This innovative approach greatly increases the chances of success, while reducing the risk of side effects. Formal human clinical trials are currently underway assessing the safety and efficacy of an investigational oral therapy, ‘APPA’ in the treatment of osteoarthritis, a common and devastating disease with limited treatment options and no cure. APPA is also being evaluated in other inflammatory diseases and other molecules are also under investigation. AKL Research & Development Ltd, trading as AKL Therapeutics Ltd, welcomes enquiries from potential investors and partners as we continue the development and commercialisation process.

Industry
Pharmaceutical Manufacturing
Company size
2-10 employees
Headquarters
Stevenage, England
Type
Privately Held
Specialties
Pharmaceutical, Healthcare, Innovation, Innovative Medicine, Drug Development, Research and Development, R&D, Osteoarthritis, Alzheimer’s, Asthma, Inflammatory Disease, Scleroderma, Systemic sclerosis, and Inflammation

Locations

Employees at AKL Therapeutics

Updates

Similar pages

Browse jobs

Funding

AKL Therapeutics 1 total round

Last Round

Grant

US$ 881.5K

Investors

Innovate UK
See more info on crunchbase